Rhodiola Sachalinensis supplementation for targeted health support.
Higher salidroside, minimal rosavins (R. rosea has both). Different compound profile but similar traditional uses. Less clinical research.
Not clearly either. Just different. The salidroside content might matter for specific effects, but clinical comparisons don't exist.
Curiosity, specific interest in high-salidroside Rhodiola, or traditional use. Most people should stick with R. rosea due to better evidence.
Click through to the studies bar for the evidence base.
See the dosing guide below.
Compare formats before buying.
Some ingredients build up over weeks. Others act fast.
The compound effect of consistent dosing.
Check the cautions section if you have a pre-existing condition.
Some ingredients you feel. Others just work in the background.
Probably not unless specifically labeled. Most commercial Rhodiola is R. rosea. Species confusion is common in the market.
A large island in Russia's Far East, north of Japan. Cold climate with unique plant biodiversity. The species is named after this origin.
No compelling reason to. R. rosea has much more research. R. sachalinensis is more of a specialty interest.
Most research uses 0.4g daily. Below 0.2g, you're probably wasting money. Above 0.6g, no extra benefit. The curve plateaus. Safe upper limit ~ 0.8g.
Rhodiola Sachalinensis has emerging evidence.
Native to Sakhalin Island and surrounding Russian Far East territories. Grows in mountainous, cold regions. One of several Rhodiola species with traditional use.
Rhodiola Sachalinensis interacts with other supplements and meds. The analyzer flags interactions, dose mismatches, and timing collisions across your whole list.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.